Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Controlled Trial Into the Role of Ramipril in Fibrosis Reduction in Rheumatic Heart Disease: The RamiRHeD Trial Protocol

NCT03991910 is registered in ClinicalTrials.gov with Indonesia University as lead sponsor.

NCT NCT03991910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03991910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Controlled Trial Into the Role of Ramipril in Fibrosis Reduction in Rheumatic Heart Disease: The RamiRHeD Trial Protocol
Lead sponsor
Indonesia University
Phase
Phase 3
Overall status
Unknown status
Start date
June 27, 2019
Completion date
August 8, 2024
Enrollment
66 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ace inhibitor, fibrosis; heart, mitral stenosis, rheumatic heart disease, rheumatic mitral stenosis